 Cytomegalovirus
"Cytomegalovirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.
| Descriptor ID |
D003587
|
| MeSH Number(s) |
B04.280.382.150.150 B04.909.204.382.150.150
|
| Concept/Terms |
Cytomegalovirus- Cytomegalovirus
- Cytomegaloviruses
- Salivary Gland Viruses
- Salivary Gland Virus
- Virus, Salivary Gland
- Viruses, Salivary Gland
|
Below are MeSH descriptors whose meaning is more general than "Cytomegalovirus".
Below are MeSH descriptors whose meaning is more specific than "Cytomegalovirus".
This graph shows the total number of publications written about "Cytomegalovirus" by people in this website by year, and whether "Cytomegalovirus" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 0 | 1 | 1 | | 1986 | 1 | 0 | 1 | | 1991 | 1 | 0 | 1 | | 1992 | 2 | 0 | 2 | | 1994 | 1 | 1 | 2 | | 1995 | 1 | 0 | 1 | | 1998 | 2 | 0 | 2 | | 1999 | 5 | 1 | 6 | | 2001 | 2 | 0 | 2 | | 2002 | 2 | 2 | 4 | | 2003 | 3 | 1 | 4 | | 2004 | 4 | 1 | 5 | | 2005 | 0 | 1 | 1 | | 2006 | 1 | 1 | 2 | | 2007 | 3 | 0 | 3 | | 2008 | 3 | 1 | 4 | | 2009 | 1 | 0 | 1 | | 2010 | 2 | 0 | 2 | | 2011 | 2 | 1 | 3 | | 2012 | 2 | 0 | 2 | | 2013 | 1 | 0 | 1 | | 2014 | 2 | 1 | 3 | | 2015 | 2 | 1 | 3 | | 2016 | 2 | 1 | 3 | | 2017 | 1 | 0 | 1 | | 2018 | 1 | 1 | 2 | | 2019 | 1 | 0 | 1 | | 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cytomegalovirus" by people in Profiles.
-
Gianella S, Moser C, Vitomirov A, McKhann A, Layman L, Scott B, Caballero G, Lada S, Bosch RJ, Hoenigl M, Lurain N, Landay A, Lederman MM, Hunt PW, Smith D. Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events. AIDS. 2020 05 01; 34(6):849-857.
-
Hodowanec AC, Pikis A, Singer ME. The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory Perspective. J Infect Dis. 2020 03 05; 221(Suppl 1):S109-S112.
-
Komatsu TE, Hodowanec AC, Colberg-Poley AM, Pikis A, Singer ME, O'Rear JJ, Donaldson EF. In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products. Antiviral Res. 2019 09; 169:104549.
-
Letendre S, Bharti A, Perez-Valero I, Hanson B, Franklin D, Woods SP, Gianella S, de Oliveira MF, Heaton RK, Grant I, Landay AL, Lurain N. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis. 2018 08 16; 67(5):770-777.
-
Santos CAQ, Brennan DC. Cytomegalovirus: A Guide for the Perplexed. Transplantation. 2018 06; 102(6):898-899.
-
Camargo JF, Kimble E, Rosa R, Shimose LA, Bueno MX, Jeyakumar N, Morris MI, Abbo LM, Simkins J, Alencar MC, Benjamin C, Wieder E, Jimenez A, Beitinjaneh A, Goodman M, Byrnes JJ, Lekakis LJ, Pereira D, Komanduri KV. Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients. Biol Blood Marrow Transplant. 2018 04; 24(4):806-814.
-
Cohen T, Williams JD, Opperman TJ, Sanchez R, Lurain NS, Tortorella D. Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication. J Virol. 2016 Dec 01; 90(23):10715-10727.
-
Fayek SA, Beshears E, Lieber R, Alvey N, Sauer A, Poirier J, Hollinger EF, Olaitan OK, Jensik S, Geyston J, Brokhof MM, Hodowanec AC, Hertl M, Simon DM. Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease. Transplant Proc. 2016 Jul-Aug; 48(6):2056-2064.e1.
-
Santos CA, Brennan DC, Saeed MJ, Fraser VJ, Olsen MA. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage. Clin Transplant. 2016 Apr; 30(4):435-44.
-
Hodowanec A, Williams B, Hanson B, Livak B, Keating S, Lurain N, Adeyemi OM. Soluble CD163 But Not Soluble CD14 Is Associated With Cytomegalovirus Immunoglobulin G Antibody Levels in Virologically Suppressed HIV+ Individuals. J Acquir Immune Defic Syndr. 2015 Dec 15; 70(5):e171-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|